Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Complete Spinal Cord Injury Treatment Using Autologous Bone Marrow Cell Transplantation and Bone Marrow Stimulation with Granulocyte Macrophage‐Colony Stimulating Factor: Phase I/II Clinical Trial
The BMC transplantation and GM‐CSF administration were not associated with any serious adverse clinical events increasing morbidities, and the AIS grade increased in 30.4% of the acute and subacute treated patients, whereas no significant improvement was observed in the chronic treatment group.
Minimization of Immunosuppressive Therapy After Islet Transplantation: Combined Action of Heme Oxygenase‐1 and PEGylation to Islet
- D. Y. Lee, S. Lee, J. Nam, Y. Byun
- Biology, MedicineAmerican journal of transplantation : official…
- 1 August 2006
It is demonstrated that the combinatorial protocol of initial induction of heme oxygenase‐1 expression, followed by the daily administration of a low dose CsA after transplantation of PEGylated islets can be employed as a successful cell therapy in clinical islet transplantation.
Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.
The newly developed FDC of amlodipine adipate/valsartan and amlidipine besylate / valsartan combination tablets met the regulatory criteria for bioequivalence and no significant difference was observed in the safety assessments between two treatments.